Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 4
2005 1
2006 1
2010 1
2011 2
2013 1
2014 1
2015 2
2016 1
2017 1
2018 2
2019 2
2020 3
2022 2
2023 3
2024 1
2025 1
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
Pediatric Immune Thrombocytopenia.
Gotesman M, Shear M, Raheel S, Procassini M, Panosyan EH. Gotesman M, et al. Among authors: panosyan eh. Adv Pediatr. 2024 Aug;71(1):229-240. doi: 10.1016/j.yapd.2024.02.007. Epub 2024 Apr 6. Adv Pediatr. 2024. PMID: 38944486 Review.
A Phase 3 Trial of l-Glutamine in Sickle Cell Disease.
Niihara Y, Miller ST, Kanter J, Lanzkron S, Smith WR, Hsu LL, Gordeuk VR, Viswanathan K, Sarnaik S, Osunkwo I, Guillaume E, Sadanandan S, Sieger L, Lasky JL, Panosyan EH, Blake OA, New TN, Bellevue R, Tran LT, Razon RL, Stark CW, Neumayr LD, Vichinsky EP; Investigators of the Phase 3 Trial of l-Glutamine in Sickle Cell Disease. Niihara Y, et al. Among authors: panosyan eh. N Engl J Med. 2018 Jul 19;379(3):226-235. doi: 10.1056/NEJMoa1715971. N Engl J Med. 2018. PMID: 30021096 Free article. Clinical Trial.
Chronic Myeloid Leukemia in Children and Adolescents.
Gotesman M, Raheel S, Panosyan EH. Gotesman M, et al. Among authors: panosyan eh. Adv Pediatr. 2023 Aug;70(1):145-155. doi: 10.1016/j.yapd.2023.04.002. Epub 2023 May 12. Adv Pediatr. 2023. PMID: 37422292 Review.
WITHDRAWN: Single-Cell Heterogeneity of EGFR Pathway Is Linked to Unique Signatures of Drug Response and Malignancy in Patient Derived Glioblastoma Stem Cells.
Masterman-Smith MD, Graham NA, Panosyan EH, Mottahedeh J, Samuels ER, Nunez A, Phillips T, Choe M, Cloughesy TF, Lazareff JA, Liau LM, Yong WH, Graeber TG, Kornblum HI, Lang MF, Li Y, Sun J. Masterman-Smith MD, et al. Among authors: panosyan eh. Cancer Res Treat. 2025 Jan 7. doi: 10.4143/crt.2024.859. Online ahead of print. Cancer Res Treat. 2025. PMID: 39788641 Free article. Retracted.
28 results